Anti-U3 ribonucleoprotein antibody-positive inflammatory myopathy: A case report

Journal of Medical Case Reports

Volumn 10, Issue 1, 2016, Pages

  Murata, Ken Ya ^a   Nakatani, Kumiko ^a   Yananeki, Mika ^a   Nakanishi, Ichiro ^a   Ito, Hidefumi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti U3 RNP antibody; Cricopharyngeal bar; Polymyositis; Steroid therapy

Indexed keywords

CD8 ANTIGEN; CREATINE KINASE; MYOGLOBIN; PREDNISOLONE; RIBONUCLEOPROTEIN ANTIBODY; U3 RIBONUCLEOPROTEIN ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; GLUCOCORTICOID; RIBONUCLEOPROTEIN, U3 SMALL NUCLEOLAR; SMALL NUCLEOLAR RIBONUCLEOPROTEIN;

AGED; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CONNECTIVE TISSUE; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DYSPHAGIA; EDEMA; ELECTROMYOGRAPHY; ENDOMYSIUM; GAIT DISORDER; HORMONAL THERAPY; HUMAN; JAPANESE (PEOPLE); MALE; MEDICAL HISTORY; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE WEAKNESS; MYOPATHY; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; POLYMYOSITIS; PRIORITY JOURNAL; PROSTATE CANCER; QUADRICEPS FEMORIS MUSCLE; BIOPSY; COMPLICATION; IMMUNOLOGY; PATHOLOGY; SKELETAL MUSCLE;

AGED; AUTOANTIBODIES; BIOPSY; DIAGNOSIS, DIFFERENTIAL; ELECTROMYOGRAPHY; GLUCOCORTICOIDS; HUMANS; MALE; MUSCLE, SKELETAL; MYOSITIS; POLYMYOSITIS; PREDNISOLONE; RIBONUCLEOPROTEINS, SMALL NUCLEOLAR;

EID: 84975229949     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/s13256-016-0941-4     Document Type: Article

References (8)

1. Baserga SJ, Yang XD, Steitz JA. An intact Box C sequence in the U3 snRNA is required for binding of fibrillarin, the protein common to the major family of nucleolar snRNPs. EMBO J. 1991;10:2645-51.
2. Okano Y, Steen VD, Medsger Jr TA. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum. 1992;35:95-100.
3. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971-82.
4. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromusc Disord. 2004;14:337-45.
5. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. Classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;2013(65):2737-47.
6. Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Senecal JL. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther. 2007;9:R78.
7. Oh TH, Brumfield KA, Hoskin TL, Stolp KA, Murray JA, Bassford JR. Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc. 2007;82:441-7.
8. Murata KY, Kouda K, Tajima F, Kondo T. A dysphagia study in patients with sporadic inclusion body myositis (s-IBM). Neurol Sci. 2012;33:765-70.